Cancer

The Damon Runyon Cancer Research Foundation Launches New Seed Investment Program to Catalyze Biotech Funding

The Innovative Ventures in Early-Stage Technologies Program Provides Damon Runyon Alumni Scientists with Their First Seed Check to Help Fill…

7 months ago

MD Anderson and HealthEx Announce Collaboration to Develop New Platform to Give Patients Direct Control of Data Access

Platform aims to simplify and improve patient consent process to strengthen future initiativesHOUSTON and SAN FRANCISCO, June 09, 2025 (GLOBE…

7 months ago

Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives

R&D and cross-functional operations will be centralized in a single location to enhance collaboration and operational efficiency.Tevogen.AI, strengthened by its…

7 months ago

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

Seasoned finance executive brings over 20 years of public company and capital markets experience to support clinical-stage growthHOUSTON, June 09,…

7 months ago

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer…

7 months ago

PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC

Event to Discuss the Changing Landscape of HNSCC in context with the Merck KN-689 study and the Rapidly Increasing Incidences…

7 months ago

Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

Company Is Advancing Use of Novel Doxorubicin-containing Microneedle Array (D-MNA) Patch in Veterinary Oncology as an Orphan DrugPhiladelphia, Pennsylvania--(Newsfile Corp.…

7 months ago

Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology

Montreal, Quebec--(Newsfile Corp. - June 9, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a…

7 months ago

Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall…

7 months ago